Biotechnology
Medical
Female CEOs

GlycoMimetics

1,525

$2.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.44%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell GlycoMimetics and other stocks, options, ETFs, and crypto commission-free!

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. Read More The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

CEO
Rachel K. King
Employees
57
Headquarters
Rockville, Maryland
Founded
2003
Market Cap
91.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
498.46K
High Today
$2.17
Low Today
$1.94
Open Price
$2.07
Volume
436.15K
52 Week High
$13.44
52 Week Low
$1.82

Collections

Biotechnology
Medical
Female CEOs
Health
Technology
2014 IPO
US

GLYC Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 1, Pre-Market

People Also Bought

Aurora Cannabis

870,118

$0.8096

-2.84%

Aurora Cannabis

870,118

$0.8096

-2.84%

Hexo

178,579

$0.676

-6.45%

Viking Therapeutics

51,598

$4.31

-4.01%

You May Also Like

ASUR
CVNA
WF
FORTY
OLEM
EFO
CHRA
FICO
GII
FLRN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy GLYC

Market Price$2.11
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell GlycoMimetics stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up